Clinical Trials · NCT03072147

Teriparatide as a Chondroregenerative Therapy in OA

Name: Teriparatide as a Chondroregenerative Therapy in OA
Creator: Peptide Science Daily
License: https://clinicaltrials.gov/about-site/terms-conditions

CompletedPhase 2Teriparatide

Phase: Phase 2
Recruitment status: Completed
Sponsor: Christopher Ritchlin
Enrollment: 76
Start date: May 2017
Locations: 1 site, United States
Primary endpoint: Knee MRI

View Teriparatide compound reference